Nadifloxacin
| Nadifloxacin | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | Topical |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | 124858-35-1 |
| PubChem | 65959 |
| DrugBank | DB09223 |
| ChemSpider | 59363 |
| KEGG | D05111 |
Nadifloxacin is a topical antibiotic used in the treatment of acne vulgaris and other bacterial skin infections. It belongs to the class of fluoroquinolone antibiotics, which are known for their broad-spectrum antibacterial activity.
Mechanism of Action[edit]
Nadifloxacin works by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes that are essential for bacterial DNA replication, transcription, and repair. This inhibition leads to the disruption of bacterial cell processes and ultimately results in bacterial cell death.
Clinical Uses[edit]
Nadifloxacin is primarily used for the treatment of acne vulgaris, a common skin condition characterized by pimples, blackheads, and whiteheads. It is also effective against other bacterial skin infections, including impetigo and folliculitis.
Side Effects[edit]
Common side effects of nadifloxacin include skin irritation, itching, and redness. Less commonly, it may cause allergic reactions such as rash, hives, and swelling.
Dosage and Administration[edit]
Nadifloxacin is typically applied topically to the affected area once or twice daily, as directed by a healthcare provider. It is important to follow the prescribed dosage and not to use the medication for longer than recommended.
Precautions[edit]
Patients should avoid exposure to sunlight or UV light while using nadifloxacin, as it can increase the risk of photosensitivity. It is also important to inform the healthcare provider of any other medications being used to avoid potential drug interactions.
See Also[edit]
References[edit]